Abdel-Salam OM, Sleem AA, Youness ER, Yassen NN, Shaffie N, El-Toumy SA (2018) Capsicum protects against rotenone-induced toxicity in mice brain via reduced oxidative stress and 5-lipoxygenase activation. J Pharm Pharmacol Res 2(3):60–77

Article  Google Scholar 

Al-Amran FG, Hadi NR, Hashim AM (2013) Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats. Eur J Cardiothorac Surg 43(2):421–427

Article  PubMed  Google Scholar 

Albertini, C. (2022). Development of new chemical entities to target neuroinflammatory pathways.

Armada-Moreira A, Gomes JI, Pina CC, Savchak OK, Gonçalves-Ribeiro J, Rei N, Vaz SH (2020) Going the extra (synaptic) mile: excitotoxicity as the road toward neurodegenerative diseases. Front Cell Neurosci 14:90

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bachurin SO, Gavrilova SI, Samsonova A, Barreto GE, Aliev G (2018) Mild cognitive impairment due to Alzheimer disease: contemporary approaches to diagnostics and pharmacological intervention. Pharmacol Res 129:216–226

Article  CAS  PubMed  Google Scholar 

Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Bumbu AG (2021a) Role of monoamine oxidase activity in Alzheimer’s disease: an insight into the therapeutic potential of inhibitors. Molecules 26(12):3724

Article  CAS  PubMed  PubMed Central  Google Scholar 

Behl T, Kaur G, Sehgal A, Bhardwaj S, Singh S, Buhas C, Bungau S (2021b) Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: pathophysiological and therapeutic perspectives. Int J Mol Sci 22(3):1413

Article  CAS  PubMed  PubMed Central  Google Scholar 

Birke FW, Meade CJ, Anderskewitz R, Speck GA, Jennewein HM (2001) In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B4 receptor antagonist. J Pharmacol Exp Ther 297(1):458–466

CAS  PubMed  Google Scholar 

Bradburn S, Murgatroyd C, Ray N (2019) Neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a meta-analysis. Ageing Res Rev 50:1–8

Article  CAS  PubMed  Google Scholar 

Brzica H, Abdullahi W, Ibbotson K, Ronaldson PT (2017) Role of transporters in central nervous system drug delivery and blood-brain barrier protection: relevance to treatment of stroke. J Central Nerv Syst Dis 9:1179573517693802

Google Scholar 

Butola LK, Dhok A, Ambad R, Kanyal D, Jha RK (2021) Leukotrienes and inflammation–a review. Indian J Forensic Med Toxicol 15(2):295–301

Article  CAS  Google Scholar 

Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer’s disease: current evidence and future directions. Alzheimers Dement 12(6):719–732

Article  PubMed  Google Scholar 

Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL (2009) 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes. Obesity 17(9):1657–1663

Article  CAS  PubMed  Google Scholar 

Chen Y, Wu H, Wang S, Koito H, Li J, Ye F, Lu QR (2009) The oligodendrocyte-specific G protein–coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci 12(11):1398–1406

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Yang Y, Li CT, Zhang SR, Zheng W, Wei EQ, Zhang LH (2015) CysLT2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro. Brain Res 1624:433–445

Article  CAS  PubMed  Google Scholar 

Chen F, Ghosh A, Wu F, Tang S, Hu M, Sun H, Hong H (2017) Preventive effect of genetic knockdown and pharmacological blockade of CysLT1R on lipopolysaccharide (LPS)-induced memory deficit and neurotoxicity in vivo. Brain Behav Immunity 60:255–269

Article  CAS  Google Scholar 

Chen F, Ghosh A, Lin J, Zhang C, Pan Y, Thakur A, Tang S (2020) 5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer’s disease. Brain Behav Immun 88:844–855

Article  CAS  PubMed  Google Scholar 

Chou VP, Holman TR, Manning-Bog AB (2013) Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability. Neuroscience 228:73–82

Article  CAS  PubMed  Google Scholar 

Chu J, Praticò D (2011) Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer’s disease transgenic mouse model: involvement of γ-secretase. Am J Pathol 178(4):1762–1769

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu J, Praticò D (2016) The 5-Lipoxygenase as modulator of Alzheimer’s γ-secretase and therapeutic target. Brain Res Bull 126:207–212

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu J, Giannopoulos PF, Ceballos-Diaz C, Golde TE, Pratico D (2012) Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice. Mol Neurodegener 7:1–10

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu J, Lauretti E, Di Meco A, Praticò D (2013) FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo. Transl Psychiatry 3(12):e333–e333

Article  CAS  PubMed  PubMed Central  Google Scholar 

Claesson, H. E., Sjöberg, J., Xu, D., & Björkholm, M. (2024). Expression and putative biological roles of lipoxygenases and leukotriene receptors in leukemia and lymphoma. Prostaglandins & Other Lipid Mediators, 106871.

Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35(1):441–468

Article  CAS  PubMed  PubMed Central  Google Scholar 

Czapski GA, Czubowicz K, Strosznajder JB, Strosznajder RP (2016) The lipoxygenases: their regulation and implication in Alzheimer’s disease. Neurochem Res 41:243–257

Article  CAS  PubMed  Google Scholar 

Ding Q, Wei EQ, Zhang YJ, Zhang WP, Chen Z (2006) Cysteinyl leukotriene receptor 1 is involved in N-methyl-D-aspartate-mediated neuronal injury in mice. Acta Pharmacol Sin 27(12):1526–1536

Article  CAS  PubMed  Google Scholar 

Fang SH, Wei EQ, Zhou Y, Wang ML, Zhang WP, Yu GL, Chen Z (2006) Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience 140(3):969–979

Article  CAS  PubMed  Google Scholar 

Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Praticò D (2008) 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer’s disease. FASEB J off Publ Fed Am Soc Exp Biol 22(4):1169

CAS  Google Scholar 

Fumagalli M, Lecca D, Abbracchio MP (2016) CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17. Neuropharmacology 104:82–93

Article  CAS  PubMed  Google Scholar 

Gelders G, Baekelandt V, Van der Perren A (2018) Linking neuroinflammation and neurodegeneration in Parkinson’s disease. J Immunol Res 2018(1):4784268

PubMed  PubMed Central  Google Scholar 

Gelosa P, Colazzo F, Tremoli E, Sironi L, Castiglioni L (2017) Cysteinyl leukotrienes as potential pharmacological targets for cerebral diseases. Mediators Inflamm 2017(1):3454212

PubMed  PubMed Central  Google Scholar 

Ghosh A, Chen F, Thakur A, Hong H (2016) Cysteinyl leukotrienes and their receptors: emerging therapeutic targets in central nervous system disorders. CNS Neurosci Ther 22(12):943–951

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghosh A, Chen F, Wu F, Tang SS, Hu M, Long Y, Hong H (2017) CysLT1R downregulation reverses intracerebroventricular streptozotocin-induced memory impairment via modulation of neuroinflammation in mice. Progress Neuro-Psychopharmacol Biol Psychiatr 73:19–30

Article